A 38-year-old woman with a history of recurrent biliary colic presents with jaundice, pale stools, and dark urine. Laboratory tests show elevated direct bilirubin and alkaline phosphatase. Abdominal ultrasound confirms dilated intrahepatic bile ducts and a dilated common bile duct (8 mm) but no gallstones are visualized. Which investigation is most appropriate to identify the cause of biliary obstruction?

Explanation

## Investigation of Choice for Suspected Biliary Obstruction ### Why MRCP is Correct **Key Point:** MRCP is the **non-invasive gold standard** for visualizing the biliary tree and pancreatic ducts. It has excellent sensitivity and specificity for detecting choledocholithiasis, strictures, and other causes of obstruction without requiring endoscopy or contrast injection. **High-Yield:** MRCP is preferred as the **diagnostic investigation** when: - Biliary obstruction is suspected but ultrasound findings are inconive (dilated ducts but no stone visualized) - Need to identify the **exact cause** (stone, stricture, malignancy, sphincter dysfunction) - Patient is at risk for ERCP complications (altered anatomy, coagulopathy) - Non-invasive confirmation is required before therapeutic intervention ### Clinical Context This patient has: - Dilated intrahepatic and common bile ducts (8 mm; normal < 6 mm) - No gallstones on ultrasound → suggests **choledocholithiasis** (stone in CBD, not visualized on US) or other obstruction - Elevated direct bilirubin and ALP → cholestasis pattern MRCP will: 1. Visualize the entire biliary tree and pancreatic duct 2. Identify stones, strictures, or masses 3. Guide whether ERCP (therapeutic) is needed ### Comparison of Diagnostic Modalities | Investigation | Sensitivity for CBD Stone | Specificity | Invasiveness | Therapeutic Capability | Best Use | |---|---|---|---|---|---| | **MRCP** | 90–95% | 95%+ | Non-invasive | No | Diagnostic imaging of choice | | Hepatobiliary scintigraphy | 60–70% | Moderate | Non-invasive | No | Assess biliary kinetics, not stone detection | | CT abdomen | 70–85% | Good | Non-invasive | No | Detect malignancy, assess pancreas | | ERCP | 95%+ | 95%+ | Invasive | Yes | Therapeutic (sphincterotomy, stone extraction) | **Clinical Pearl:** ERCP is reserved for **therapeutic intervention** (stone extraction, stent placement), not diagnostic confirmation. Using ERCP diagnostically exposes the patient to pancreatitis risk (3–5%) unnecessarily. **Mnemonic:** **MRCP for Diagnosis, ERCP for Treatment** — MRCP is non-invasive and diagnostic; ERCP is invasive and therapeutic. **Tip:** In NEET PG, when the stem asks for the **investigation of choice** to **identify the cause** of obstruction, choose MRCP. If the question asks for **definitive management** or **therapeutic intervention**, then ERCP is appropriate.